Furthermore, based on the recent evidence showing that STING pathways in cancer cells may be also involved in cell death induction [38,39,40], we believe that an effective delivery of STING and MAVS through PBMC-EXs may enhance the suppression of tumor growth and activate an antitumor immunity response. Here, STING1 is linked to cancer.